Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
54.77
-2.41 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
54.23
-0.54 (-0.99%)
After-hours: Apr 28, 2026, 5:41 PM EDT
Spruce Biosciences Employees
Spruce Biosciences had 8 employees as of December 31, 2025. The number of employees decreased by 13 or -61.90% compared to the previous year.
Employees
8
Change (1Y)
-13
Growth (1Y)
-61.90%
Revenue / Employee
n/a
Profits / Employee
-$4,870,750
Market Cap
148.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Alps Group | 93 |
| Agenus | 81 |
| Tenaya Therapeutics | 70 |
| Spero Therapeutics | 25 |
| Black Diamond Therapeutics | 21 |
SPRB News
- 7 days ago - Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 8 days ago - Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 7 weeks ago - Spruce Biosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Spruce Biosciences Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates - Business Wire
- 7 weeks ago - Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer - Business Wire
- 2 months ago - Spruce Biosciences to Present at Upcoming Investor Conferences in March - Business Wire
- 2 months ago - Spruce Biosciences Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts